Evidence map›Paper›PMID 29479196›Full record

ArticlePaediatrics & child health2017

Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial.

François Olivier, Sophie Nadeau, Sylvie Bélanger, Anne-Sophie Julien, Edith Massé, Nabeel Ali, Georges Caouette, Bruno Piedboeuf

Open access · bronzeAbstract read
In one paragraph

Article in Paediatrics & child health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 6 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 6 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Effects of a respiratory care protocol incorporating less invasive surfactant administration in infants born at 30-34 weeks' gestation.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  11. Review
  12. Minimally invasive surfactant therapy outcomes in infants born at 28-37 weeks' gestation.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

François OlivierDepartment of Pediatrics, CHU de Québec - Université Laval, Québec City, Québec.
Sophie NadeauDepartment of Pediatrics, CHU de Québec - Université Laval, Québec City, Québec.
Sylvie BélangerDepartment of Pediatrics, CHU de Québec - Université Laval, Québec City, Québec.
Anne-Sophie JulienPlateforme de la recherche clinique, Centre de recherche du CHU de Québec - Université Laval, Hôpital Saint-François d'Assise, Québec City, Québec.
Edith MasséDepartment of Pediatrics, Université de Sherbrooke, Hôpital Fleurimont, Sherbrooke, Québec.
Nabeel AliDepartment of Pediatrics, Université de Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Québec.
Georges CaouetteDepartment of Pediatrics, CHU de Québec - Université Laval, Québec City, Québec.
Bruno PiedboeufDepartment of Pediatrics, CHU de Québec - Université Laval, Québec City, Québec.
Université Laval · CAUniversité de Montréal · CAUniversité de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMinimally invasive surfactant therapy (MIST) is a new strategy to avoid mechanical ventilation (MV) in respiratory distress syndrome. The primary aim of this study was to test MIST as a means of avoiding MV exposure and pneumothorax occurrence in moderate and late preterm infants (32 to 36 weeks' gestational age).

methodsThis was a randomized controlled trial including three Canadian centres. Patients were randomized to standard management or to the intervention if they required nasal continuous positive airway pressure of 6 cm H

resultsAmong 45 randomized patients, 24 were assigned to MIST and 21 to standard management. Eight infants (33%) from the intervention group met the primary outcome criteria versus 19 (90%) in the control group (absolute risk reduction 0.57, 95% confidence interval 0.54 to 0.60). One patient in each group reached the primary outcome because of pneumothorax occurrence. The other patients were exposed to MV. None of the patients reached the clinical failure criteria.

conclusionMIST for respiratory distress syndrome management in moderate and late preterm infants was associated with a significant reduction of MV exposure and pneumothorax occurrence.

Indexed as

Hyaline membrane diseaseInfantPrematurePulmonary surfactantsRespiratory distress syndromeSpontaneous breathing.

Identifiers

PMID29479196
PMCPMC5804903
OpenAlexW2608816162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.